Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review

S Zivkovic, G Maric, N Cvetinovic… - Nutrients, 2023 - mdpi.com
Cardiovascular diseases (CVD) are the leading cause of death worldwide. Since the
establishment of the “lipid hypothesis”, according to which, cholesterol level is directly …

Present and future of dyslipidaemia treatment—a review

I Merćep, A Vujević, D Strikić, I Radman, I Pećin… - Journal of Clinical …, 2023 - mdpi.com
One of the greatest burdens on the healthcare systems of modern civilization is
cardiovascular diseases (CVDs). Therefore, the medical community is looking for ways to …

[HTML][HTML] The utility of 3D models to study cholesterol in cancer: insights and future perspectives

TL du Plessis, N Abdulla, M Kaur - Frontiers in Oncology, 2023 - frontiersin.org
Cholesterol remains a vital molecule required for life; however, increasing evidence exists
implicating cholesterol in cancer development and progression. Numerous studies …

StackER: a novel SMILES-based stacked approach for the accelerated and efficient discovery of ERα and ERβ antagonists

N Schaduangrat, N Homdee, W Shoombuatong - Scientific Reports, 2023 - nature.com
The role of estrogen receptors (ERs) in breast cancer is of great importance in both clinical
practice and scientific exploration. However, around 15–30% of those affected do not see …

Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms

R Li, Y Wu, Y Li, W Shuai, A Wang, Y Zhu, X Hu… - European Journal of …, 2023 - Elsevier
Colorectal cancer (CRC), a tumor of the digestive system, is characterized by high
malignancy and poor prognosis. Currently, targeted therapy of CRC is far away from …

[HTML][HTML] Lomitapide Repurposing for Treatment of Malignancies: A Promising Direction

HT Wu, BX Wu, ZX Fang, Z Wu, YY Hou, Y Deng… - Heliyon, 2024 - cell.com
The development of novel drugs from basic science to clinical practice requires several
years, much effort, and cost. Drug repurposing can promote the utilization of clinical drugs in …

Enhancing the anticancer immune response with the assistance of drug repurposing and delivery systems

Z Fu, X Zhang, Y Gao, J Fan… - Clinical and Translational …, 2023 - Wiley Online Library
Background The immune system plays a pivotal role in the initiation, evolution, invasion and
metastasis of cancer. Therapeutics aiming at modulating or boosting anticancer immune …

Lipid-lowering drugs and cancer: an updated perspective

A Alizadehasl, MS Alavi, S Boudagh, MS Alavi… - Pharmacological …, 2024 - Springer
Statins and non-statin medications used for the management of dyslipidemia have been
shown to possess antitumor properties. Since the use of these drugs has steadily increased …

Revealing the role of epigenetic and post-translational modulations of autophagy proteins in the regulation of autophagy and cancer: a therapeutic approach

SG Chowdhury, P Karmakar - Molecular Biology Reports, 2024 - Springer
Autophagy is a process that is characterized by the destruction of redundant components
and the removal of dysfunctional ones to maintain cellular homeostasis. Autophagy …

Association between metabolic reprogramming and immune regulation in digestive tract tumors

J Liu, T Wang, W Zhang, Y Huang, X Wang… - Oncology Research and …, 2024 - karger.com
Background: The cancers of the digestive tract, including colorectal cancer (CRC), gastric
cancer, and esophageal cancer, are part of the most common cancers as well as one of the …